A multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients

Samsung Medical Center0 个研究点目标入组 2,000 人开始时间: 待定最近更新: 2023年11月13日

适应症

试验速览

暂无简介。

•1. Patients diagnosed with the following lymphoid malignancies through histopathological diagnostic procedures, regardless of whether they were previously treated:
•1) Hodgkin lymphoma
•2) B-cell non-Hodgkin lymphoma
•3) T or NK cell non-Hodgkin lymphoma
•4) Diseases included in the category of lymphoid malignancies in other WHO classifications
•2. Patients over 20 years of age
•3. Patients who gave written consent to participate in a prospective cohort study

•1. In case of malignant tumor of the lymphatic system that falls under any of the following diseases:
•yes; Plasma cell disease, amyloidosis
•2. If you are a patient with the following lymphatic malignancies:
•1) In case of follow-up observation after diagnosis because treatment is not necessary
•2) When only local radiation therapy is planned for the purpose of anticancer treatment
•3) When using only antiviral drugs, antibiotics, or steroids rather than anticancer drugs for the purpose of anticancer treatment
•3. Patients who do not understand or do not agree to written consent

发起方